Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Read More…
Industry, Sector and Symbol
Industry Toilet preparations
Sub-IndustryHousehold Products
SectorConsumer Staples
Phone212-310-2000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$15.54 billion
Profitability
Miscellaneous
Employees34,500
Next Earnings Date10/25/2019 (Estimated)
OptionableOptionable
Colgate-Palmolive (NYSE:CL) Frequently Asked Questions
What is Colgate-Palmolive's stock symbol?
Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."
How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?
Colgate-Palmolive announced a quarterly dividend on Wednesday, September 11th. Investors of record on Wednesday, October 23rd will be paid a dividend of $0.43 per share on Friday, November 15th. This represents a $1.72 dividend on an annualized basis and a yield of 2.42%. The ex-dividend date is Tuesday, October 22nd. View Colgate-Palmolive's Dividend History.
How will Colgate-Palmolive's stock buyback program work?
Colgate-Palmolive announced that its board has initiated a share buyback program on Monday, June 18th 2018, which allows the company to buyback $5,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to buy up to 9% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board of directors believes its stock is undervalued.
How were Colgate-Palmolive's earnings last quarter?
Colgate-Palmolive (NYSE:CL) announced its quarterly earnings results on Friday, July, 26th. The company reported $0.72 earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of $0.72. The company had revenue of $3.87 billion for the quarter, compared to analyst estimates of $3.88 billion. Colgate-Palmolive had a negative return on equity of 10,821.98% and a net margin of 14.77%. The company's quarterly revenue was down .5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.77 EPS. View Colgate-Palmolive's Earnings History.
When is Colgate-Palmolive's next earnings date?
What price target have analysts set for CL?
16 Wall Street analysts have issued twelve-month price objectives for Colgate-Palmolive's stock. Their forecasts range from $65.00 to $82.00. On average, they anticipate Colgate-Palmolive's stock price to reach $73.8462 in the next year. This suggests a possible upside of 4.1% from the stock's current price. View Analyst Price Targets for Colgate-Palmolive.
What is the consensus analysts' recommendation for Colgate-Palmolive?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 1 sell rating, 9 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Colgate-Palmolive.
What are Wall Street analysts saying about Colgate-Palmolive stock?
Here are some recent quotes from research analysts about Colgate-Palmolive stock:
- 1. Wells Fargo & Co analysts commented, "We are raising our price target by $3 to $68 to reflect CL’s fundamental progress to date, but maintain our Market Perform rating largely on valuation." (6/17/2019)
- 2. According to Zacks Investment Research, "Colgate surpassed the industry year to date owing to a robust surprise trend, which continued in first-quarter 2019. This marked the second straight quarter of sales beat and third positive earnings surprise of the last five quarters. Robust volumes and favorable pricing aided organic sales growth in the quarter. In 2019, the company expects benefits of pricing and productivity programs to considerably offset rise in raw material costs. Accelerated investments in brands, strong innovation, and expansion in new markets and channels, is likely to aid sales in 2019. However, the company is plagued with a soft margins and currency headwinds for a while now. Increased raw material and packaging costs as well as higher SG&A expenses are likely to hurt margins throughout 2019. Further, adverse currency should mar earnings and sales in 2019." (6/7/2019)
Has Colgate-Palmolive been receiving favorable news coverage?
Media stories about CL stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Colgate-Palmolive earned a news impact score of -1.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Colgate-Palmolive.
Are investors shorting Colgate-Palmolive?
Colgate-Palmolive saw a increase in short interest in August. As of August 15th, there was short interest totalling 11,271,000 shares, an increase of 12.6% from the July 15th total of 10,012,100 shares. Based on an average daily volume of 3,340,000 shares, the short-interest ratio is presently 3.4 days. Currently, 1.3% of the company's stock are short sold. View Colgate-Palmolive's Current Options Chain.
Who are some of Colgate-Palmolive's key competitors?
Some companies that are related to Colgate-Palmolive include Estee Lauder Companies (EL), Coty (COTY), Pola Orbis (PORBF), HYPERA S A/S (HYPMY), Inter Parfums (IPAR), Avon Products (AVP), Edgewell Personal Care (EPC), Mandom (MDOMF), Revlon (REV), e.l.f. Beauty (ELF), United-Guardian (UG), 2050 Motors (ETFM) and DS Healthcare Group (DSKX).
What other stocks do shareholders of Colgate-Palmolive own?
Who are Colgate-Palmolive's key executives?
Colgate-Palmolive's management team includes the folowing people:
- Mr. Ian M. Cook, Exec. Chairman (Age 66)
- Mr. Noel R. Wallace, Pres, CEO & Director (Age 55)
- Mr. Henning I. Jakobsen, Chief Financial Officer (Age 59)
- Mr. P. Justin Skala, Exec. VP and Chief Growth & Strategy Officer (Age 59)
- Dr. Patricia D. Verduin Ph.D., Chief Technology Officer (Age 60)
Who are Colgate-Palmolive's major shareholders?
Colgate-Palmolive's stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.92%), BlackRock Inc. (7.02%), BlackRock Inc. (7.02%), Bank of New York Mellon Corp (2.37%), Northern Trust Corp (1.27%) and Invesco Ltd. (1.01%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive.
Which institutional investors are selling Colgate-Palmolive stock?
CL stock was sold by a variety of institutional investors in the last quarter, including D. E. Shaw & Co. Inc., Morgan Stanley, AXA, Marathon Asset Management LLP, Commonwealth Bank of Australia, Renaissance Technologies LLC, Caisse DE Depot ET Placement DU Quebec and Amundi Pioneer Asset Management Inc.. Company insiders that have sold Colgate-Palmolive company stock in the last year include Dennis J Hickey, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran and Stephen I Sadove. View Insider Buying and Selling for Colgate-Palmolive.
Which institutional investors are buying Colgate-Palmolive stock?
CL stock was bought by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Invesco Ltd., AQR Capital Management LLC, Vanguard Group Inc., Natixis, Natixis, Panagora Asset Management Inc. and California Public Employees Retirement System. View Insider Buying and Selling for Colgate-Palmolive.
How do I buy shares of Colgate-Palmolive?
Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Colgate-Palmolive's stock price today?
One share of CL stock can currently be purchased for approximately $70.95.
How big of a company is Colgate-Palmolive?
Colgate-Palmolive has a market capitalization of $60.88 billion and generates $15.54 billion in revenue each year. The company earns $2.40 billion in net income (profit) each year or $2.97 on an earnings per share basis. Colgate-Palmolive employs 34,500 workers across the globe.View Additional Information About Colgate-Palmolive.
What is Colgate-Palmolive's official website?
How can I contact Colgate-Palmolive?
Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]
MarketBeat Community Rating for Colgate-Palmolive (NYSE CL)
MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe CL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.
